11C-labeled stilbene derivatives as Abeta-aggregate-specific PET imaging agents for Alzheimer's disease. - Wikidata - awgldk - TriplyDB

11C-labeled stilbene derivatives as Abeta-aggregate-specific PET imaging agents for Alzheimer's disease.

11C-labeled stilbene derivatives as Abeta-aggregate-specific PET imaging agents for Alzheimer's disease.

http://www.wikidata.org/entity/Q44538097

about

Insight into the Molecular Imaging of Alzheimer's Disease PET amyloid-beta imaging in preclinical Alzheimer's disease What have novel imaging techniques revealed about metabolism in the aging brain?Near-infrared fluorescent probes for imaging of amyloid plaques in Alzheimer׳s disease Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain.FDG- and amyloid-PET in Alzheimer's disease: is the whole greater than the sum of the parts?Synthesis and evaluation of novel chalcone derivatives with (99m)Tc/Re complexes as potential probes for detection of β-amyloid plaques.Rhodanine and thiohydantoin derivatives for detecting tau pathology in Alzheimer's brains.BODIPY-based molecular probe for imaging of cerebral β-amyloid plaques.Quick assembly of 1,4-diphenyltriazoles as probes targeting beta-amyloid aggregates in Alzheimer's disease.Quantitative multimodal multiparametric imaging in Alzheimer's disease.Enhanced radiosyntheses of [¹¹C]raclopride and [¹¹C]DASB using ethanolic loop chemistry.F-18 stilbenes as PET imaging agents for detecting beta-amyloid plaques in the brain.Synthesis of biphenyltrienes as probes for beta-amyloid plaques.Small-molecule theranostic probes: a promising future in neurodegenerative diseases.Small organic probes as amyloid specific ligands--past and recent molecular scaffolds.Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging.Amyloid-β probes: Review of structure-activity and brain-kinetics relationships.Novel Benzofurans with (99m)Tc Complexes as Probes for Imaging Cerebral β-Amyloid Plaques Fluorinated Benzofuran Derivatives for PET Imaging of β-Amyloid Plaques in Alzheimer's Disease Brains.(18)F-labeled phenyldiazenyl benzothiazole for in vivo imaging of neurofibrillary tangles in Alzheimer's disease brains.Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.Nanoparticulate radiolabelled quinolines detect amyloid plaques in mouse models of Alzheimer's disease Evaluation of [11C]TAZA for amyloid β plaque imaging in postmortem human Alzheimer's disease brain region and whole body distribution in rodent PET/CT.SPECT Imaging Agents for Detecting Cerebral β-Amyloid Plaques.Enhanced fluorescent assignment of protein aggregates by an oligothiophene-porphyrin-based amyloid ligand.Novel indanone derivatives as potential imaging probes for β-amyloid plaques in the brain.Preparation and stability of ethanol-free solution of [18F]florbetapir ([18F]AV-45) for positron emission tomography amyloid imaging.Studies into radiolytic decomposition of fluorine-18 labeled radiopharmaceuticals for positron emission tomography.Coordination Chemistry of Bifunctional Chemical Agents Designed for Applications in 64Cu PET Imaging for Alzheimer's Disease.La lunga attesa: towards a molecular approach to neuroimaging and therapeutics in Alzheimer's disease.Rhenium and technetium complexes that bind to amyloid-β plaques.Advances in molecular imaging for the diagnosis of dementia.(E)-5-styryl-1H-indole and (E)-6-styrylquinoline derivatives serve as probes for β-amyloid plaques.Imaging of amyloid deposition in human brain using positron emission tomography and [18F]FACT: comparison with [11C]PIB.A Pyridazine-Based Fluorescent Probe Targeting Aβ Plaques in Alzheimer's Disease.Pyrroloquinoxaline hydrazones as fluorescent probes for amyloid fibrils

P2860

Q26765945-72D0DE9D-B440-4942-94FF-3A37B6599AD7 Q30040695-33F676CB-8965-4439-8B3C-0249B5CBD432 Q30850844-6BE81F72-06F4-485D-BC5B-4D1FCD5B4A8A Q31025427-D24B77DC-973F-4399-A3D7-A47EC9835C3A Q31093609-DD3C79EE-7E0C-41D8-844F-4C15069AA270 Q34725521-12DD781E-01AD-4F5E-BD37-8415C30E4EB8 Q35792038-2C996ED3-642F-4B41-BB54-544FA382F778 Q36012379-C70FFA8A-8A24-4ACD-B79B-7D78B8D35FD9 Q36015406-7D63647B-A3B5-4C9F-83D5-D5DC5F88EAFB Q36015598-BE84D7CD-0D29-4F2E-B0EE-1569CFD402C3 Q36028775-93D24A22-8D29-476C-B7DC-A9A6A33B24CD Q36164757-6F5D2BD8-51EE-4123-BB92-5EA097C90040 Q36446162-F6DF67DE-0025-4025-AFDC-8D708219B986 Q36996052-6EC784A1-01EA-47DE-A13E-F0B3BD2C73BC Q37003006-3C84B946-3668-4F1D-AC13-E0B85B43F0CA Q37353880-0D8CCE1C-BA0C-4ECA-A1B0-ACBB56CFBDCC Q37450061-1600448A-DF76-41F5-B7F8-8307D4BED2D2 Q37698055-4EF44005-40C7-48C0-9E3D-DB03D025DAFE Q38114434-040B4D99-BD88-4365-BA77-366F580FACC5 Q39152073-1266288A-AA1A-4008-BF92-558CF9BC31AD Q39157899-5F502E48-794E-4C97-AD3B-FC3A87F9D5A3 Q39736843-522818AA-F334-4B4C-B6B6-C2C3BDE453F3 Q40415499-20FEF4FB-B27A-44AD-A39E-50D11A614220 Q41861393-C7E96818-2DFC-4088-8DDE-F4089F6542F8 Q42315307-F4E5DF3B-E93C-4412-A399-59BAFE9CA6EF Q42734136-9C5ECF80-5529-4C09-9C32-1807DEF603F6 Q43664322-78A943BD-40F7-4359-826F-36774793DEED Q44328803-75D0D894-3361-45B0-B8DB-C0BBAF3DC22E Q45889671-61DBA55A-AF79-42F0-A0FD-3177B4BD9DF9 Q46297141-7AC4FDC5-9234-480B-BFF3-910B29DF184C Q46924077-DF021354-10BC-4169-AF88-452C632EC239 Q48396205-1BAF16EB-AD26-45C8-A4E4-43495D520378 Q48409925-1CD25A7F-B053-4189-B54E-61A2FA1A3713 Q48420736-9903EC9C-8175-4DA9-A105-4A9F3716E7B1 Q48575140-63862299-E999-4C5D-AF39-B618333E12EE Q48872380-8826C467-A990-4CCA-944D-1069993B8C35 Q52571135-51719F79-E4E9-4669-8212-CE2F20A49707 Q58855717-8E818CDD-D166-4447-B294-8366AE1C059B

P2860

11C-labeled stilbene derivatives as Abeta-aggregate-specific PET imaging agents for Alzheimer's disease.

http://www.wikidata.org/entity/Q44538097

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

11C-labeled stilbene derivativ ...... gents for Alzheimer's disease.

@en

11C-labeled stilbene derivativ ...... gents for Alzheimer's disease.

@nl

type

label

11C-labeled stilbene derivativ ...... gents for Alzheimer's disease.

@en

11C-labeled stilbene derivativ ...... gents for Alzheimer's disease.

@nl

prefLabel

11C-labeled stilbene derivativ ...... gents for Alzheimer's disease.

@en

11C-labeled stilbene derivativ ...... gents for Alzheimer's disease.

@nl

P1433

Q44538097-04A1D463-CB66-42A6-B38A-0004CD1B7C62

P1476

Q44538097-E307DFCF-1C4F-480B-816C-A1C08E852FD8

P2093

Q44538097-6000E702-B28E-47EF-A55C-0CC7D1CD5E21

Q44538097-740F6F27-FC52-4A8E-9E57-64EBA42B5EC0

Q44538097-75712158-3158-47C5-97FE-13D3C0ADDB0D

Q44538097-8690A7CA-0B84-4608-BF21-4CC46AC8604E

Q44538097-BCB8E9AE-106C-449D-8C72-6C065D3F921F

Q44538097-C26F4F3E-828B-4314-8DFA-F98FFA62A2FF

Q44538097-E3D59086-E7EC-407E-A059-2E0F9EBCA3E7

Q44538097-FACC51B3-1C04-4F65-A128-436B9A56DFEC

P304

Q44538097-B88B0C1B-6A0F-4008-8971-C9C0D563C829

P31

Q44538097-DC218BF8-4D37-43E2-9AC0-F731E434A990

P356

Q44538097-F6D8698C-B0BD-48D1-B1A6-6F3BA60B0CA9

P433

Q44538097-CAC18D56-EF57-4084-9BA9-7BB73373F53F

P478

Q44538097-E68C1A8F-F765-4C53-915F-4ACEC9840640

P577

Q44538097-9201054C-2ABA-4D04-96B1-9E0184871CFC

P698

Q44538097-D3C1A381-41FB-4B45-AED2-4FAA4F61A8A8

P921

Q44538097-25AAB4EA-01BB-44B4-8ABF-EFA4D2E66C38

P356

S0969-8051(03)00049-0

P1433

Nuclear Medicine and Biology

P1476

11C-labeled stilbene derivativ ...... gents for Alzheimer's disease.

@en

P2093

Alan Wilson

http://www.w3.org/2001/XMLSchema#string

David Westaway

http://www.w3.org/2001/XMLSchema#string

Hank F Kung

http://www.w3.org/2001/XMLSchema#string

Jose Nobrega

http://www.w3.org/2001/XMLSchema#string

Masahiro Ono

http://www.w3.org/2001/XMLSchema#string

Mei-Ping Kung

http://www.w3.org/2001/XMLSchema#string

Paul Verhoeff

http://www.w3.org/2001/XMLSchema#string

Zhi-Ping Zhuang

http://www.w3.org/2001/XMLSchema#string

P304

565-571

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0969-8051(03)00049-0

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2003-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12900282

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease